Thiol-ene polymerization with vinylesters and vinylcarbonate

Patent metadata

Field	Value
Publication number	US-2016243279-A1
Application number	US-201615146951-A
Country	US
Kind code	A1
Filing date	May 5, 2016
Priority date	Oct 3, 2011
Publication date	Aug 25, 2016
Grant date	—

Abstract

The present disclosure is directed, in part, to a curable composition, a method for augmenting a structure in a patient with a resorbable biocompatible polymer, and a biodegradable, resorbable implant comprising a biocompatible copolymer. An exemplary embodiment of the curable composition comprises (a) 60 wt. % to 95 wt. % of one or more vinyl ester monomers and/or vinylcarbonate monomers, wherein said one or more vinyl ester monomers and/or vinylcarbonate monomers are respectively selected from compounds of the general formulas (I) and (II) below:

wherein n, m R 1 and R 2 have the meaning defined herein; (b) 0.1 to 40 wt. % of one or more multifunctional thiols; and (c) 0 to 10 wt. % of a biocompatible polymerization initiator.

First claim

1 . A curable composition comprising:
(a) 60 wt. % to 95 wt. % of one or more vinylcarbonate monomers, wherein said one or more vinylcarbonate monomers are respectively selected from compounds of the general formula (II) below:

wherein
n and m independently range from 2 to 1000;
R 2 is independently selected from the group consisting of:
(i) n-valent radicals, each of said n-valent radicals comprising a carbon chain or a carbon cycle or both,

wherein said carbon chain and/or carbon cycle each, independently from one another, comprises from 1 to 30 carbon atoms,
wherein said carbon chain can be straight, branched, saturated or unsaturated, and optionally containing one or more interspersed heteroatoms, said heteroatoms being selected from the group consisting of oxygen, sulfur and nitrogen, and/or
wherein said carbon chain optionally being substituted with one or more substituents selected from the group consisting of —OH, —COOH, —CN, —CHO, and ═O,
wherein said carbon cycle can be saturated or unsaturated, and optionally containing one or more interspersed heteroatoms, said heteroatoms being selected from the group consisting of oxygen, sulfur and nitrogen, and/or
wherein said carbon cycle optionally being substituted with one or more substituents selected from the group consisting of —OH, —COOH, —CN, —CHO, and ═O, and
(ii) n-valent radicals of biodegradable, biocompatible oligomers and polymers, said oligomers and polymers being selected from the group consisting of polysaccharides, polypeptides, polyamides, polyesters, polycarbonates, polyethers, and fatty acid derivatives;

(b) 0.1 to 40 wt. % of one or more multifunctional thiols;
(c) 0 to 10 wt. % of a biocompatible polymerization initiator; and
(d) a bioactive agent.

2 . The curable composition according to claim 1 , wherein at least one vinylcarbonate monomers of the general formula (II), accounts for 50 mole percent of all monomers contained.

3 . The curable composition according to claim 1 , wherein at least 50, mole percent of all vinyl carbonate monomers are difunctional, cross linking monomers in which n=2.

4 . The curable composition according to claim 1 , wherein said one or more vinylcarbonate monomers are selected from the group consisting of ethylene glycol bis(vinyl carbonate) (EGDVC); 1,4-butanediol bis(vinyl carbonate) (BDDVC); 1,6-hexanediol bis(vinyl carbonate) (HDDVC); glycerine tris(vinyl carbonate) (GTVC); diethylene glycol bis(vinyl carbonate) (DEGDVC); polyethylene glycol (400) bis(vinyl carbonate) (PEGDVC); ricinus oil tris(vinyl carbonate) (RiTVC); hydrated ricinus oil tris(vinyl carbonate) (HRiTVC); and diethylene glycol bis[O—(O′-vinyloxycarbonyl) polylactate] (DEG(PLAVC) 2 ).

5 . The curable composition according to claim 1 , wherein R 2 is derived from one or more diols, said one or more diols being selected from the group consisting of: 1,3-propanediol, 1,4-butanediol, 1,5-pentanediol, 1,6-hexanediol, 1,7-heptanediol, 1,8-octanediol, 1,9-nonanediol, 1,10-decanediol, and 1,12-dodecanediol.

6 . The curable composition according to claim 1 , wherein R 2 is derived from one or more diols, said one or more diols comprising a polyethylene glycol or a polypropylene glycol.

7 . The curable composition of claim 6 , wherein said polyethylene glycol has a molecular weight ranging from 200 g/mole to 1000 g/mole.

8 . (canceled)

9 . The curable composition according to claim 1 , wherein said one or more vinyl carbonate monomers are selected from the group consisting of ethylene glycol bis(vinyl carbonate) (EGDVC); 1,4-butanediol bis(vinyl carbonate) (BDDVC); 1,6-hexanediol bis(vinyl carbonate) (HDDVC); glycerine tris(vinyl carbonate) (GTVC); diethylene glycol bis(vinyl carbonate) (DEGDVC); polyethylene glycol(400) bis(vinyl carbonate) (PEGDVC); and ricinus oil tris(vinyl carbonate) (RiTVC).

10 . The curable composition according to claim 1 , wherein said one or more multifunctional thiols are selected from the group consisting of: pentaerythritol tetra-(3-mercaptopropionate), ethoxylated pentaerythritol tetra-(3-mercaptopropionate), trimethylpropane tri(3-mercapto-propionate) and ethoxylated trimethylpropane tri(3-mercapto-propionate).

11 - 12 . (canceled)

13 . The curable composition according to claim 1 , wherein said one or more vinyl carbonate monomers are selected from the group consisting of:

wherein n is an integer from 1 to 12.

14 . The curable composition according to claim 13 , wherein said one or more vinyl carbonate monomers comprise 1,4-Butanediol bis(vinyl carbonate)

15 . The curable composition according to claim 1 , wherein said one or more multifunctional thiols are selected from the group consisting of:

16 . The curable composition according to claim 1 , wherein said one or more multifunctional thiols are selected from the group consisting of: Glycol Dimercaptoacetate; Trimercaptoacetate; Pentaerythritol Tetramercaptoacetate; Ethoxylated trimethylolpropane Tri-3-mercaptopropionate; Ethoxylated trimethylolpropane Tri-3-mercaptopropionate; polypropylene glycol (3-mercaptopropionate); and (polypropylene glycol (3-mercaptopropionate).

17 . A method for augmenting or filling a structure in a patient comprising,
implanting the curable composition into said patient at a site of the structure; said curable composition comprising: (a) 60 wt. % to 95 wt. % of one or more vinylcarbonate monomers, wherein said one or more vinylcarbonate monomers are respectively selected from compounds of the general formula (II) below:

wherein
n and m independently range from 2 to 1000;
R 2 is independently selected from the group consisting of:
(i) n-valent radicals, each of said n-valent radicals comprising a carbon chain or a carbon cycle or both,

wherein said carbon chain and/or carbon cycle each, independently from one another, comprises from 1 to 30 carbon atoms,
wherein said carbon chain can be straight, branched, saturated or unsaturated, and optionally containing one or more interspersed heteroatoms, said heteroatoms being selected from the group consisting of oxygen, sulfur and nitrogen, and/or
wherein said carbon chain optionally being substituted with one or more substituents selected from the group consisting of —OH, —COOH, —CN, —CHO, and ═O,
wherein said carbon cycle can be saturated or unsaturated, and optionally containing one or more interspersed heteroatoms, said heteroatoms being selected from the group consisting of oxygen, sulfur and nitrogen, and/or
wherein said carbon cycle optionally being substituted with one or more substituents selected from the group consisting of —OH, —COOH, —CN, —CHO, and ═O, and
(ii) n-valent radicals of biodegradable, biocompatible oligomers and polymers, said oligomers and polymers being selected from the group consisting of polysaccharides, polypeptides, polyamides, polyesters, polycarbonates, polyethers, and fatty acid derivatives;

(b) 0.1 to 40 wt. % of one or more multifunctional thiols; and
(c) 0 to 10 wt. % of a biocompatible polyme

Assignees

• Depuy Synthes Products Inc
• Univ Wien Tech

Inventors

• Liska Robert
• Qin Xiaohua
• Mautner Andreas

Classifications

• B33Y80/00

  Products made by additive manufacturing · CPC title

• C08L33/06

  of esters containing only carbon, hydrogen and oxygen, which oxygen atoms are present only as part of the carboxyl radical · CPC title

• A61L27/54

  Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)} · CPC title

• A61L2430/02

  for reconstruction of bones; weight-bearing implants · CPC title

• A61L27/16 Primary

  obtained by reactions only involving carbon-to-carbon unsaturated bonds · CPC title